Frank Carr, director of medical technology developer Telezon, has sold 150,000 of his shares in the company for $0.10 per share.
The sale dilutes Carr’s interest in Telezon – and therefore his voting power – to 26.94% from 28.54%.
The sale took place yesterday as part of a share purchase plan trade, the company disclosed to the ASX.
TZN shares are trading unchanged at $0.10, but have slumped from $0.16 since the beginning of February.
Join the CIO Australia group on LinkedIn. The group is open to CIOs, IT Directors, COOs, CTOs and senior IT managers.